RK-251: What we know about India’s new ‘smart’ cancer drug that ‘could replace chemotherapy’
We haven't written up this one. The Indian Express has the full story — the link below goes straight to it.
More in Health & Medicine
Andhra junior doctors cut stipend demand to 20%, reject government’s 3% offer
APJUDA cuts its demand from a 30% biennial revision to 20%, rejects the government’s 3% offer as inadequate, and seeks a hearing before the Chief Minister as the strike enters its tenth day
Disease control must adapt to disaster type: BRIN
National Research and Innovation Agency (BRIN) researcher Ristiyanto emphasized that patterns of disease intervention ...
Trump Taps Dr. Heidi Overton to Lead FDA
The White House health aide has guided health policies in the president’s second term, including his executive order to pare back childhood vaccines.
Africa: WHO Declares Polio Outbreaks Over in Five African Countries
[Premium Times] WHO explained that the transmission was interrupted through targeted vaccination campaigns, epidemiological investigations and expanded environmental surveillance.
Mankind Pharma Licenses Two Insulin Products, Expands Diabetes Portfolio
Mumbai: Mankind Pharma has entered into an exclusive in-licensing and marketing agreement with China-based Chongqing Chenan Biopharmaceutical for two insulin products in India.